Neurohypophyseal peptides in aging and Alzheimer's disease

Ageing Research Reviews

Volumn 1, Issue 3, 2002, Pages 537-558

  Ishunina, Tatjana A ^a,b   Swaab, Dick F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b KURSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Aging; Alzheimer's disease; Arginine vasopressin; Estrogens; Human; Oxytocin; Paraventricular nucleus; Sex difference; Suprachiasmatic nucleus; Supraoptic nucleus

Indexed keywords

ARGININE; CORTICOTROPIN RELEASING FACTOR; NEUROHORMONE; NEUROHYPOPHYSIS HORMONE; NEUROTRANSMITTER; OXYTOCIN; PEPTIDE; VASOPRESSIN; ARGIPRESSIN;

ADIPOSE TISSUE; AGING; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; AUTONOMIC INNERVATION; BRAIN; BRAIN NERVE CELL; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; DIAGONAL BAND OF BROCA; ELECTROLYTE METABOLISM; ENDOCRINE GLAND; GLOBUS PALLIDUS; HUMAN; HYPOTHALAMUS; KIDNEY FAILURE; MEDIAN EMINENCE; MEYNERT BASAL NUCLEUS; NEUROENDOCRINOLOGY; NONHUMAN; REVIEW; SEASONAL VARIATION; SEPTUM NUCLEUS; STRIA TERMINALIS; SUPRACHIASMATIC NUCLEUS; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; ANIMAL; ANTERIOR HYPOTHALAMUS; CHEMISTRY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

TERMINALIS;

AGING; ALZHEIMER DISEASE; ANIMALS; ARGININE VASOPRESSIN; HUMANS; OXYTOCIN; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY HORMONES, POSTERIOR; SUPRAOPTIC NUCLEUS;

EID: 0036593177     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-1637(02)00013-2     Document Type: Review

References (130)

1. Albert S.G., Nakra B.R., Grossberg G.T., Caminal E.R. Vasopressin response to dehydration in Alzheimer's disease. J. Am. Geriatr. Soc. 37:1989;843-847.
2. Asplund R., Aberg H. Diurinal variation in the levers of antidiuretic hormone in the elderly. J. Int. Med. 229:1991;131-134.
3. Baylis P.H. Osmoregulation and control of vasopressin secretion in healthy humans. Am. J. Physiol. 253:1987;R671-R678.
4. Boer G.J., Van Rheenen-Verberg C.M.H., Uylings H.B.M. Impaired brain development of the diabetes insipidus Brattleboro rat. Dev. Brain Res. 3:1982;557-575.
5. Brockhaus H. Beitrag zur normalen Anatomie des Hypothalamus und der Zona incerta beim Menschen. J. Psychol. Neurol. 51:1942;96-196.
6. Brownstein M.J., Russell J.T., Gainer H. Synthesis, transport and release of posterior pituitary hormones. Science. 207:1980;373-378.
7. Buijs R.M., Kalsbeek A. Hypothalamic integration of central and peripheral clocks. Nat. Rev. Neurosci. 2:2001;521-526.
8. Cajal y Ramón, S. 1995. Histology of the nervous system of man and vertebrates. In: History of Neuroscience (N. Swanson, L.W. Swanson, Transl.). Oxford University Press, Oxford (Original work published in 1911).
9. Caldwell J.D., Prange A.F., Pederson C.A. Oxytocin facilitates the sexual receptivity of estrogen-treated female rats. Neuropeptides. 7:1986;175-189.
10. Cantau B., Keppens S., De Wulf H., Jard S. Vasopressin binding to isolated rat hepatocytes and liver membranes: regulation by GTP and regulation to glycogen phosphorylase activation. J. Recept. Res. 1:1980;137-168.
11. Carmichael M.S., Humbert R., Dixen J., Palmisano G., Greenleaf W., Davidson J.M. Plasma oxytocin increases in the human sexual response. J. Clin. Endocrinol. Metab. 64:1987;27-31.
12. Chiodera P., Volpi R., Capretti L., Caiazza A., Marchesi M., Caffari G., Rossi G., Coiro V. Oxytocin response to challenging stimuli in elderly men. Regular. Pept. 51:1994;169-176.
13. Crowe M.J., Forsling M.L., Rolls B.J., Phillips P.A., Ledingham J.G., Smith R.F. Altered water excretion in healthy elderly men. Age Ageing. 16:1987;285-293.
14. Cui L.-N., Jolley C.J., Dyball R.E.J. Electrophysiological evidence for retinal projections to the hypothalamic supraoptic nucleus and its perinuclear zone. J. Neuroendocrinol. 9:1997;347-353.
15. Dai J., Van der Vliet J., Swaab D.F., Buijs R.M. Human retinohypothalamic tract as revealed by in vitro postmortem tracing. J. Comp. Neurol. 397:1998;357-370.
16. De Lacalle S., Iraizoz I., Gonzalo L.M. Cell loss in supraoptic and paraventricular nucleus in Alzheimer's disease. Brain Res. 609:1993;154-158.
17. De Wied D., van Ree J.M. Neuropeptides: animal behaviour and human psychopathology. Eur. Arch. Psychiatry Neurol. Sci. 238:1989;323-331.
18. De Wied D., Gaffori O., Van Ree J.M., De Jong W. Central target for the behavioral effects of vasopressin neuropeptide. Nature. 308:1984;276-278.
19. Dechant G., Rodriguez-Tebar A., Barde Y.A. Neurotrophin receptors. Prog. Neurobiol. 42:1994;347-352.
20. Diepen, R., 1962. Handbuch der mikroskopischen Anatomie des Menschen. Nervensystem, Bd. 4, T. 7. Der Hypothalamus, Berlin.
21. Dierickx K., Vandesande F. Immunocytochemical localization of the vasopressinergic and the oxytocinergic neurons in the human hypothalamus. Cell Tissue Res. 184:1977;15-27.
22. Dierickx K., Vandesande F. Immunocytochemical demonstration of separate vasopressin-neurophysin and oxytocin-neurophysin neurons in the human hypothalamus. Cell Tissue Res. 196:1979;203-212.
23. Dodt C., Dittmann J., Hruby J., Spath-Schwalbe E., Born J., Schuttler R., Fehm H.L. Different regulation of adrenocorticotropin and cortisol secretion in young, mentally healthy elderly and patients with senile dementia of Alzheimer's type, mentally healthy elderly and patients with senile dementia of Alzheimer's type. J. Clin. Endocrinol. Metab. 72:1991;272-276.
24. Duggan J., Kilfeather S., Lightman S.L., O'Malley K. The association of age with plasma arginine vasopressin and plasma osmolality. Age Ageing. 22:1993;332-336.
25. Dustan H.P. Gender differences in hypertension. J. Hum. Hypertens. 10:1996;337-340.
26. Evans J.J. Oxytocin in the human-regulation of derivations and destinations. Eur. J. Endocrinol. 137:1997;559-571.
27. Fahrbach S.E., Morrell J.I., Pfaff D.W. Possible role of endogenous oxytocin in estrogen-facilitated maternal behavior in rats. Neuroendocrinology. 40:1985;526-532.
28. Fehm-Wohlsdorf G., Born J., Voigt K.H., Fehm H.L. Human memory and neurohypophyseal hormone: opposite effects of vasopressin and oxytocin. Psychoneuroendocrinology. 9:1984;285-292.
29. Fliers E., Swaab D.F., Pool C.W., Verwer R.W.H. The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus changes with aging and in senile dementie. Brain Res. 342:1985;45-53.
30. Fliers E., Guldenaar S.E., van de Wal N., Swaab D.F. Extrahypothalamic vasopressin and oxytocin in the human brain presence of vasopressin cells in the bed nucleus of the stria terminalis. Brain Res. 375:1986;363-367.
31. Forsling M.L., Montgomery H., Halpin D., Windle R.J., Treacher D.F. Daily patterns of secretion of neurohypophysical hormones in man: effect of age. Exp. Physiol. 83:1998;409-418.
32. Frolkis V.V., Golovchenko S.F., Medved V.I., Frolkis R.A. Vasopressin and cardiovascular system in aging. Gerontology. 28:1982;290-302.
33. Fujiyoshi K., Suga H., Okamoto K., Nakamura S., Kameyama M. Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia. J. Neurol. Neurosurg. Psychiatry. 50:1987;929-932.
34. Goudsmit E., Fliers E., Swaab D.F. Vasopressin and oxytocin excretion in the Brown-Norway rat in relation to aging, water metabolism and testosterone, water metabolism and testosterone. Mech. Aging Dev. 44:1988;241-252.
35. Goudsmit E., Hofman M.A., Fliers E., Swaab D.F. The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease, age and Alzheimer's disease. Neurobiol. Aging. 11:1990;529-536.
36. Gregoretti L. Contribution à l'étude du noyau supraoptique accessoire de l'homme. Acta Neuroveget. 10:1954;1-20.
37. Gurdjian E.S. The diencephalon of the albino rat. J. Comp. Neurol. 43:1927;1-114.
38. Hofman M.A., Swaab D.F. Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res. 651:1994;134-142.
39. Hofman M.A., Swaab D.F. Influence of aging on the seasonal rhythm of the vasopressin-expressing neurons in the human suprachiasmatic nucleus. Neurobiol. Aging. 16:1995;965-971.
40. Hoogendijk J.E., Fliers E., Swaab D.F., Verwer R.W.H. Activation of vasopressin neurons in the human supraoptic and paraventricular nucleus in senescence and senile dementia. J. Neurol. Sci. 69:1985;291-299.
41. Insel T.R. A neurobiological basis of social attachment. Am. J. Psychiatry. 154:1997;726-735.
42. Ishunina T.A., Swaab D.F. Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus size changes in relation to age and sex. J. Clin. Endocrinol. Metab. 84:1999;4637-4644.
43. Ishunina T.A., Salehi A., Hofman M.A., Swaab D.F. Activity of vasopressinergic neurones of the human supraoptic nucleus is age- and sex-dependent. J. Neuroendocrinol. 11:1999;251-258.
44. Ishunina T.A., Kruijver F.P.M., Balesar R., Swaab D.F. Differential expression of estrogen receptor α and β immunoreactivity in the human supraoptic nucleus in relation to sex and aging. J. Clin. Endocrinol. Metab. 85:2000a;3283-3291.
45. Ishunina T.A., Salehi A., Swaab D.F. Sex- and age-related p75 neurotrophin receptor expression in the human supraoptic nucleus. Neuroendocrinology. 71:2000;243-251.
46. Ishunina T.A., Unmehopa U.A., Dolzhikov A.A., Swaab D.F. Multinucleated arginine-vasopressin neurons in the human supraoptic nucleus: a hallmark of pulmonary pathology. Neuroendocrinology. 72:2000;318-326.
47. Johnson A.G., Crawford G.A., Kelly D., Nguyen T.V., Gyory A.Z. Arginine vasopressin and osmolality in the elderly. J. Am. Geriatr. Soc. 42:1994;399-404.
48. Jolkkonen J., Helkala E.L., Kutvonen R., Lehtinen M., Riekkinen P.J. Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance. Psychoneuroendocrinology. 14:1989;89-95.
49. Jolles J. Neuropeptides and the treatment of cognitive deficits in aging and dementia. Prog. Brain Res. 70:1986;429-441.
50. Koutcherov Y., Mai J.K., Ashwell K.W., Paxinos G. Organization of the human paraventricular hypothalamic nucleus. J. Comp. Neurol. 423:2000;299-318.
51. Labudova O., Fang-Kircher S., Cairns N., Moenkemann H., Yeghiazaryan K., Lubec G. Brain vasopressin levels in Down syndrome and Alzheimer's disease. Brain Res. 806:1998;55-59.
52. Leake A., Perry E.K., Perry R.H., Jabeen S., Fairbairn A.F., McKeith I.G., Ferrier I.N. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations. Biol. Psychiatry. 29:1991;357-364.
53. Lederis K., Pittman Q.J., Kasting N.W., Veale W., Cooper K.E. Central neuromodulatory role of vasopressin in antipyresis and in febrile convulsions. Biomed. Res. 3:1982;1-5.
54. Legros, J.J., Gilot, P., Schmitz, S., Bruwier, M., Mantanus, H., Timsit-Berthier, M., 1980. Neurohypophyseal peptides and cognitive function: a clinical approach. In: Progress in Psychoneuroendocrinology, Elsevier, Amsterdam, p. 325.
55. Levine J.D., Zhao X.S., Miselis R.R. Direct and indirect retinohypothalamic projections to the supraoptic nucleus in the female albino-rat. J. Comp. Neurol. 341:1994;214-224.
56. Liu R.Y., Zhou J.N., Hoogendijk W.J., van Heerikhuize J., Kamphorst W., Unmehopa U.A., Hofman M.A., Swaab D.F. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J. Neuropathol. Exp. Neurol. 59:2000;314-322.
57. Lucassen P.J., Ravid R., Gonatas N.K., Swaab D.F. Activation of the human supraoptic and paraventricular neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus. Brain Res. 632:1993;10-23.
58. Lucassen P.J., Salehi A., Pool C.W., Gonatas N.K., Swaab D.F. Activation of vasopressin neurons in aging and Alzheimer's disease. J. Neuroendocrinol. 6:1994;673-679.
59. Lucassen P.J., Muller M.B., Holsboer F., Bauer J., Holtrop A., Wouda J., Hoogendijk W.J., De Kloet E.R., Swaab D.F. Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am. J. Pathol. 158:2001;453-468.
60. Mai J.K., Berger K., Sofroniew M.V. Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. J. Hirnforsch. 34:1993;133-154.
61. Martignoni E., Petraglia F., Costa A., Bono G., Genazzani A.R., Nappi G. Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels. Acta Neurol. Scand. 81:1990;452-456.
62. Mazurek M.F., Beal M.F., Bird E.D., Martin J.B. Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations. Ann. Neurol. 20:1986;665-670.
63. Mazurek M.F., Beal M.F., Bird E.D., Martin J.B. Oxytocin in Alzheimer's disease: postmortem brain levels. Neurology. 37:1987;1001-1003.
64. McGregor G.P., Lang R.E. Oxytocin in the male: an old hormone growing sexy with age. Exp. Clin. Endocrinol. Diabetes. 109:2001;83-86.
65. Melis M.R., Stancampiano R., Fratta W., Argiolas A. Oxytocin concentration changes in different rat brain areas but not in plasma during aging. Neurobiol. Aging. 13:1992;783-786.
66. Miller M. Hormonal aspects of fluid and sodium balance in the elderly. Endocrinol. Metab. Clin. North Am. 24:1995;233-253.
67. Miller M. Nocturnal polyuria in older people: pathophysiology and clinical implications. J. Am. Geriatr. Soc. 48:2000;1321-1329.
68. Morton A. A quantitative analysis of the normal neuron population of the hypothalamic magnocellular nuclei in man and of their projections to the neurohypophysis. J. Comp. Neurol. 136:1969;143-158.
69. Müller M.B., Lucassen P.J., Yassouridis A., Hoogendijk W.J.G., Holsboer F., Swaab D.F. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur. J. Neurosci. 14:2001;1603-1612.
70. Murphy M.R., Seckl J.R., Burton S., Checkley S.A., Lightman S.L. Changes in oxytocin and vasopressin secretion during sexual activity in men. J. Clin. Endocrinol. Metab. 65:1987;738-741.
71. Nadal M., Wikstrom L., Ruthstrom L. Secretory pattern of vasopressin in plasma and cerebrospinal fluid in patients with dementia and of two control groups. Eur. J. Endocrinol. 130:1994;346-349.
72. Nakamura S., Koshimura K., Kato T., Yamao S., Iijima S., Nagata H., Miyata S., Fujiyoshi K., Okamoto K., Suga H.et al. Neurotransmitters in dementia. Clin. Ther. 7:1984;18-34.
73. Nitsch R.M., Kim C., Growdon J.H. Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease. Neurochem. Res. 23:1998;807-814.
74. Norbiato G., Bevilacqua M., Carella F., Chebat E., Raggi U., Bertora P., Grassi M.P., Mangoni A. Alterations in vasopressin regulation in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 51:1988;903-908.
75. Nordby G., Os I., Kjeldsen S.E., Eide I. Mild essential hypertension in nonobese pre-menopausal women is characterized by low renin. Am. J. Hypertens. 5:1992;579-584.
76. North W.G., Harbaugh R., Reeder T. An elevation of human neurophysin production in Alzheimer's disease: preliminary observations. Neurobiol. Aging. 13:1992;261-265.
77. Os I., Kjeldsen S.E., Westheim A., Akesson I., Eide I., Skjoto J., Hjermann I., Leren P. Aging and urinary vasopressin excretion in healthy men. Scand. J. Urol. Nephrol. 21:1987;235-239.
78. Pávó I., Morschl É., Szepes Z., Kiss J., Boda K., Vetró G., Varga C., László F.A., László F. Vasopressin deficiency decreases the frequency of gastroduodenal ulceration in humans. J. Physiol. 94:2000;63-66.
79. Peskind E.R., Pascualy M., Edland S.D., Wingerson D., Dobie D.J., Raskind M.A. Plasma arginine vasopressin response to hypertonic saline infusion in Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 9:1995;238-242.
80. Phillips P.A., Johnston C.I., Gray L. Disturbed fluid and electrolyte homeostasis following dehydration in elderly people. Age Ageing. 22:1993;S26-S33.
81. Pittman Q.J., Lawrence D., McLean L. Central effects of arginine vasopressin on blood pressure in rats. Endocrinology. 110:1982;1058-1060.
82. Prelevic G.M., Jacobs H.S. Menopause and post-menopause. Bailliere's Clin. Endocrinol. Metab. 11:1997;311-340.
83. Price J.F., Fowkes F.G. Risk factors and the sex difference in coronary artery disease. Epidemiology. 8:1997;584-591.
84. Purba J.S., Hofman M.A., Portegies P., Troost D., Swaab D.F. Decreased number of oxytocin neurons in the paraventricular nucleus of the human hypothalamus in AIDS. Brain. 116:1993;795-809.
85. Raadsheer F.C., Tilders F.J., Swaab D.F. Similar age-related increase of vasopressin co-localization in paraventricular corticotropin-releasing hormone neurons in controls and Alzheimer patients. J. Neuroendocrinol. 6:1994;131-133.
86. Raadsheer F.C., van Heerikhuize J.J., Lucassen P.J., Hoogendijk W.J., Tilders F.J., Swaab D.F. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry. 152:1995;1372-1376.
87. Raskind M.A., Peskind E.R., Lampe T.H., Risse S.C., Taborsky G.J. Jr., Dorsa D. Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and β-endorphin in Alzheimer's disease. Arch. Gen. Psychiatry. 43:1986;382-388.
88. Ravid R., Fliers E., Swaab D.F., Zurcher C. Changes in vasopressin and testosterone in the senescent Brown-Norway (BN/BiRij) rat. Gerontology. 33:1987;87-98.
89. Rondeau E., de Lima J., Caillens H., Ardaillou R., Vahanian A., Acar J. High plasma antidiuretic hormone in patients with cardiac failure: influence of age. Miner Electrolyte Metab. 8:1982;267-274.
90. Saper, C.B., 1990. Hypothalamus. In: Paxinos, G. (Ed.), The Human Nervous System, Academic Press, San Diego, pp. 389-413.
91. Saper C.B., German D.C. Hypothalamic pathology in Alzheimer's disease. Neurosci. Lett. 74:1987;364-370.
92. Scharrer E., Gaupp R. Neure befunde am Nucleus supraopticus and Nucleus paraventricularis des Menschen. Z. ges. Neurol. Psychiatr. 148:1933;766-772.
93. Scharrer E., Scharrer B. The hypothalamus and central levels of autonomic function. Fitel. 202:1940;170-194.
94. Schultz C., Ghebremedhin E., Braak H., Braak E. Neurofibrillary pathology in the human paraventricular and supraoptic nuclei. Acta Neuropathol. 94:1997;99-102.
95. Share L., Crofton J.T. Interactions between the gonadal steroid hormones and vasopressin and oxytocin. Ann. Acad. Sci. 689:1993;438-454.
96. Share L., Crofton J.T., Ouchi Y. Vasopressin: sexual dimorphism in secretion, cardiovascular actions and hypertension. Am. J. Med. Sci. 295:1988;314-319.
97. Standaert D.G., Lee V.M.-Y., Greenberg B.G., Lowery D.E., Trojanowski J.Q. Molecular features of hypothalamic plaques in Alzheimer's disease. Am. J. Pathol. 139:1991;681-691.
98. Stout N.R., Kenny R.A., Baylis P.H. A review of water balance in aging in health and disease. Gerontology. 45:1999;61-66.
99. Swaab D.F. The hypothalamo-neurohypophysial system and reproduction. Prog. Brain Res. 38:1972;225-244.
100. Swaab D.F. Neurohypophyseal peptides in the human hypothalamus in relation to development, sexual differentiation, aging and disease. Regulat. Pept. 45:1993;143-147.
101. Swaab D.F. Ageing of the human hypothalamus. Horm. Res. 43:1995;8-11.
102. Swaab, D.F., 1997. Neurobiology and neuropathology of the human hypothalamus. In: Bjorklund, A., Hokfelt, T. (Eds.), Handbook of Chemical Neuroanatomy. The Primate Nervous System, Part 1, Vol. 13, Elsevier, Amsterdam, pp. 39-137.
103. Swaab D.F. The human hypothalamo-neurohypophyseal system in health and disease. Prog. Brain Res. 119:1998;577-618.
104. Swaab D.F., Jongkind J.F. The hypothalamic neurosecretory activity during the oestrous cycle, pregnancy, parturition, lactation, and after gonadectomy, in the rat. Neuroendocrinology. 6:1970;133-145.
105. Swaab D.F., Jongkind J.F. Influence of gonadotropic hormones on the hypothalamic neurosecretory activity in the rat. Neuroendocrinology. 8:1971;36-47.
106. Swaab D.F., Fliers E., Partiman T.S. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. 342:1985;37-44.
107. Swaab, D.F., Fliers, E., Hoogendijk, J.E., 1987. Vasopressin in relationship to human aging and dementia. In: Gash, D.M., Boer, G.J. (Eds.), Vasopressin: Principles and Properties. Plenum Press, New York, 611-625.
108. Swaab D.F., Grundke-Iqbal I., Iqbal K., Kremer H.P.H., Ravid R., Van de Nes J.A.P. Tau and ubiquitin in the human hypothalamus in aging and Alzheimer's disease. Brain Res. 590:1992;239-249.
109. Swaab D.F., Raadsheer F.C., Endert E., Hofman M.A., Kamphorst W., Ravid R. Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid. J. Neuroendocrinol. 6:1994;681-687.
110. Swaab D.F., Purba J.S., Hofman M.A. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willy syndrome: a study of five cases. J. Clin. Endocrinol. Metab. 80:1995;573-579.
111. Swaab D.F., Lucassen P.J., Salehi A., Scherder E.J.A., van Someren E.J.W., Verwer R.W.H. Reduced neuronal activity and reactivation in Alzheimer's disease. Prog. Brain Res. 117:1998;343-377.
112. Swaab D.F., Fliers E., Hoogendijk W.J., Veltman D.J., Zhou J.N. Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression. Prog. Brain Res. 126:2000;369-396.
113. Thind K.K., Boggan J.E., Goldsmith P.C. Interactions between vasopressin and gonadotropin-releasing-hormone containing neuroendocrine neurons in the monkey supraoptic nucleus. Neuroendocrinology. 53:1991;287-297.
114. Toba K., Crofton J.T., Inoue M., Share L. Effects of vasopressin on arterial brood pressure and cardiac output in male and female rats. Am. J. Physiol. 261:1991;R1118-1125.
115. Ulfig N., Braak E., Ohm T.G., Pool C.W. Vasopressinergic neurons in the magnocellular nuclei of the human basal forebrain. Brain Res. 530:1990;176-180.
116. Van der Woude P.F., Goudsmit E., Wierda M., Purba J.S., Hofman M.A., Bogte H., Swaab D.F. No vasopressin cell loss in the human hypothalamus in aging and Alzheimer's disease. Neurobiol. Aging. 16:1995;11-18.
117. Van Londen L., Goekoop J.G., Van Kempen G.M.J., Frankhuijsen-Sierevogel A.C., Wiegant V.M., Van der Velde E.A., De Wied D. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology. 17:1997;284-292.
118. Van Someren E.J. Circadian and sleep disturbances in the elderly. Exp. Gerontol. 35:2000a;1229-1237.
119. Van Someren E.J. Circadian rhythms and sleep in human aging. Cronobiol. Int. 17:2000b;233-243.
120. Van Zwieten E.J., Ravid R., Hoogendijk W.J., Swaab D.F. Stable vasopressin innervation in the degenerating human locus coeruleus in Alzheimer's disease. Brain Res. 649:1994;329-333.
121. Van Zwieten E.J., Ravid R., Swaab D.F. Differential vasopressin and oxytocin innervation of the human parabrachial nucleus: no changes in Alzheimer's disease. Brain Res. 711:1996;146-152.
122. Verwer R.W.H., Hermens W.T.J.M.C., Dijkhuizen P.A., ter Brake O., Baker R.E., Salehi A., Sluiter A.A., Kok M.J.M., Müller L.J., Verhaagen J., Swaab D.F. Cells in human postmortem brain tissue slices remain alive for several weeks in culture. FASEB J. 16:2002;54-60.
123. Vogels O.J., Broere C.A., Nieuwenhuys R. Neuronal hypertrophy in the human supraoptic and paraventricular nucleus in aging and Alzheimer's disease. Neurosci. Lett. 109:1990;62-67.
124. Wallin A., Gottfries C.G. Biochemical substrates in normal aging and Alzheimer's disease. Pharmacopsychiatry. 23:1990;37-43.
125. Wallin A., Carlsson A., Ekman R., Gottfries C.G., Karlsson I., Svennerholm L., Widerlov E. Hypothalamic monoamines and neuropeptides in dementia. Eur. Neuropsychopharmacol. 1:1991;165-168.
126. Wang Y.X., Edvards R.M., Nambi P., Stack K.J., Pullen M., Share L., Crofton J.T., Brooks D.P. Effects of gonadectomy on sexually dimorphic antidiuretic action of vasopressin in conscious rats. Am. J. Physiol. 267:1994;R536-541.
127. Wang Y.X., Crofton J.T., Liu H., Sato K., Brooks D.P., Share L. Estradiol attenuates the antidiuretic action of vasopressin in ovariectomized rats. Am. J. Physiol. 268:1995;R951-957.
128. Wierda M., Goudsmit E., Van der Woude P.F., Purba J.S., Hofman M.A., Bogte H., Swaab D.F. Oxytocin cell number in the human paraventricular nucleus remains constant with aging and in Alzheimer's disease. Neurobiol. Aging. 12:1991;511-516.
129. Wolters E.C., Riekkinen P., Lowenthal A., Van der Plaats J.J., Zwart J.M., Sennef C. DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trial. Neurology. 40:1990;1099-1101.
130. Zhang X., Hense H.W., Riegger G.A., Schunkert H. Association of arginine vasopressin and arterial blood pressure in a population-based sample. J. Hypertens. 17:1999;319-324.